_version_ 1783729919851757568
author Ciuffreda, Laura
Lorenzo-Salazar, José M.
Alcoba-Florez, Julia
Rodriguez-Pérez, Héctor
Gil-Campesino, Helena
Íñigo-Campos, Antonio
García-Martínez de Artola, Diego
Valenzuela-Fernández, Agustín
Hayek-Peraza, Marcelino
Rojo-Alba, Susana
Alvarez-Argüelles, Marta Elena
Díez-Gil, Oscar
González-Montelongo, Rafaela
Flores, Carlos
author_facet Ciuffreda, Laura
Lorenzo-Salazar, José M.
Alcoba-Florez, Julia
Rodriguez-Pérez, Héctor
Gil-Campesino, Helena
Íñigo-Campos, Antonio
García-Martínez de Artola, Diego
Valenzuela-Fernández, Agustín
Hayek-Peraza, Marcelino
Rojo-Alba, Susana
Alvarez-Argüelles, Marta Elena
Díez-Gil, Oscar
González-Montelongo, Rafaela
Flores, Carlos
author_sort Ciuffreda, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-8316714
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83167142021-07-28 Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia Ciuffreda, Laura Lorenzo-Salazar, José M. Alcoba-Florez, Julia Rodriguez-Pérez, Héctor Gil-Campesino, Helena Íñigo-Campos, Antonio García-Martínez de Artola, Diego Valenzuela-Fernández, Agustín Hayek-Peraza, Marcelino Rojo-Alba, Susana Alvarez-Argüelles, Marta Elena Díez-Gil, Oscar González-Montelongo, Rafaela Flores, Carlos J Infect Letters to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-11 2021-07-28 /pmc/articles/PMC8316714/ /pubmed/34329678 http://dx.doi.org/10.1016/j.jinf.2021.07.028 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters to the Editor
Ciuffreda, Laura
Lorenzo-Salazar, José M.
Alcoba-Florez, Julia
Rodriguez-Pérez, Héctor
Gil-Campesino, Helena
Íñigo-Campos, Antonio
García-Martínez de Artola, Diego
Valenzuela-Fernández, Agustín
Hayek-Peraza, Marcelino
Rojo-Alba, Susana
Alvarez-Argüelles, Marta Elena
Díez-Gil, Oscar
González-Montelongo, Rafaela
Flores, Carlos
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title_full Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title_fullStr Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title_full_unstemmed Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title_short Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
title_sort longitudinal study of a sars-cov-2 infection in an immunocompromised patient with x-linked agammaglobulinemia
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316714/
https://www.ncbi.nlm.nih.gov/pubmed/34329678
http://dx.doi.org/10.1016/j.jinf.2021.07.028
work_keys_str_mv AT ciuffredalaura longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT lorenzosalazarjosem longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT alcobaflorezjulia longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT rodriguezperezhector longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT gilcampesinohelena longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT inigocamposantonio longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT garciamartinezdeartoladiego longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT valenzuelafernandezagustin longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT hayekperazamarcelino longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT rojoalbasusana longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT alvarezarguellesmartaelena longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT diezgiloscar longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT gonzalezmontelongorafaela longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia
AT florescarlos longitudinalstudyofasarscov2infectioninanimmunocompromisedpatientwithxlinkedagammaglobulinemia